http://blog.viaccess-orca.com/industry/jaws-part-1

New Post Public Reply Private Reply Replies (0) Message Board
2can
http://blog.viaccess-orca.com/industry/jaws-p...e=facebook


Jaws – Part 1: Smelling the Sweet Blood of User Experience

June 18, 2014 l By David Leporini 


.

It looks like a shark fin – a sudden, abrupt and massive technology adoption, followed by a rapid decline upon the arrival of a new disruptive technology wave. In Big Bang Disruption, Downes and Nunes turn Roger’s classic bell curve of technology demand model on its head, now taking the form of a threatening dorsal.

The essence of their argument is that technological advances have enabled new players in the software and internet industries to launch products whose sales rapidly outperform those of established rivals, but then fall off just as quickly, as a new so-called Big Bang Disruptor is launched.

Forget the traditional adoption segments which were once adopted: innovators, early adopters, early majority, late majority, and laggards – welcome trial users first, and then everybody else once a product and its business model align to successfully disrupt an existing market.

This is the red ocean content service providers should be successfully navigating today. And in this world of ever-growing choices and finite time where power has moved from sellers to buyers, the sweet blood is all about user experience and consumer engagement as they fuel service monetization opportunities. In this new content consumption paradigm, the two main business questions content service providers should be obsessed with right now are the following:

• How to create an engaging universe around content services to grab these monetization opportunities?
• How to prevent piggybacking on content services that has the potential to massively divert or even destroy monetization opportunities?

Here comes the challenge for content service providers: If they want to guard against falling victim to Big Bang Disruption, they cannot just “create or prevent” – but rather “create and prevent”.

We have entered an era of technology volatility where winning companies need to either build open global technology platforms themselves (think iOS, Android, Facebook, Twitter, or Amazon Web Services today) or embrace such platforms to build value-added products and services. They need to do this again, and again, and again; faster, and faster, and faster – to have a chance to surf this volatility wave.

The issue is about competition between content service providers. It’s about defensive incumbents versus newcomers fully embracing new content consumption paradigms. It’s about value and monetization opportunities migrating in the content service value chain to just where end-users want to be. And it’s about the dark shark fin content service providers should be worried about.

Content piracy has always been an attempt at delivering a competing user experience through illegitimate products and services under a different and presumably more compelling business model regime.

Digital disruption may be shaking this very rule though, possibly enabling a tipping point to be reached: the ability to deliver to end-users an even better experience than legitimate content service providers do.

It’s achieved by leveraging cloud capabilities and internet delivery networks, piggybacking on legitimate content services to reach devices increasingly valued by end-users for content consumption, and presenting more and more compelling user interfaces.

But, at the same time, having no infrastructure to maintain and evolve, no investment in content to support, and no content rights agreement to enforce. The piracy version of aligning technology and business model – the very definition of Big Bang Disruption.

Digital Uts Ventures (DUTV) Stock Research Links

DUTV Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

LiberNovo's Black Friday Chair Sale Tests Premium Demand

Updated Category News Views 81

Ergonomic chairs are not impulse purchases, and LiberNovo knows it. Its Black Friday push in the United States and Canada runs through November 30, throwing discounts, gifts, prize-wheel entries and loyalty points at buyers considering a fairly expensive piece of office equipment. That is a lot of promotional machinery for a chair sale, but the underlying pitch is...

Continue Reading
Pennsylvania Rebate Rules Matter Before Year-End Filing

Updated Category News Views 70

A missed rebate form can sting harder than most people expect, especially when a household has already spent the year watching property taxes, rent, groceries, and every other stubborn bill chew through fixed income. Pennsylvania’s Property Tax/Rent Rebate Program is not glamorous, and it is certainly not an investing story. It is, however, the kind of direct household...

Continue Reading
First US Extends Buyback Clock Through Year-End 2027

Updated Category News Views 199

A buyback extension is not a thunderclap; it is a bank board keeping a useful tool within reach. First US Bancshares has pushed the expiration of its existing repurchase authorization from December 31, 2026, to December 31, 2027. That matters, but investors ought to resist turning a calendar change into a grand earnings prophecy. The company has bought back 2,122,972...

Continue Reading
Rare Stellar Merger Validates RIT Theory in Nature

Updated Category News Views 82

One star swallowed another’s orbit, and astronomy finally caught the evidence. That is the plain-English punch of the observation called AT 2025abao in the Andromeda Galaxy, and it is a meaningful one for Jason Nordhaus and his colleagues at Rochester Institute of Technology. On Nov. 18, research published in Nature validated a scenario Nordhaus’s team had predicted...

Continue Reading
MSD's AI Drug Bet Has Promise, but Plenty to Prove

Updated Category News Views 66

A promising molecule remains a very expensive guess until biology agrees. That is the sober lens for MSD's newly announced research collaboration with Isomorphic Labs: potentially meaningful science, certainly interesting strategic positioning, and absolutely no reason yet to start penciling in product sales. One Oncology Target, Not a Finished Drug On November 19, 2026,...

Continue Reading
LiberNovo's European Black Friday Sale Tests Demand

Updated Category News Views 139

A €1,339 chair has no business pretending it is an impulse buy, which is exactly why LiberNovo’s Black Friday push deserves a closer look. The Hong Kong-based ergonomic-chair seller has rolled out its Black Friday sale across the European Union and United Kingdom, with the campaign ending November 30 at 23:59 CET in the EU and 23:59 GMT in the UK. This is a...

Continue Reading
Sinopec's Green Fuel Push Meets a Hard Reality Check

Updated Category News Views 150

A refinery giant talking about green jet fuel at a climate summit is exactly the sort of thing that makes old energy hands squint first—and then check the asset list. Sinopec did bring more than lofty language to its Nov. 16 COP31 side event in Antalya: it brought long-range energy forecasts, named fuel-production routes, hydrogen infrastructure and operating projects....

Continue Reading
Aimbient's OR Timestamp Study Puts Efficiency to Test

Updated Category News Views 160

A camera catching a patient’s arrival on time may sound mundane, but operating rooms are where mundane details can turn into serious money and better operational decisions. Aimbient’s newly corrected announcement points to an independently conducted Stanford Medicine study in JAMA Surgery that tested whether its computer-vision system could document key operating-room...

Continue Reading
Thanksgiving AI Talk Needs Better Safety Questions

Updated Category News Views 108

Thanksgiving has somehow acquired a new household hazard: somebody casually pasting private information into a chatbot between football and dessert. SBS CyberSecurity’s point is sensible, and it lands because this is no longer a niche tech habit. Pew Research Center says 49% of U.S. adults use AI chatbots, up from roughly one-third in 2024. That kind of adoption curve...

Continue Reading
Goosehead Restatement Puts Accounting Trust on Trial

Updated Category News Views 87

A filing delay can be irritating; a multi-year no-rely warning is something uglier. Goosehead Insurance told investors on November 9, 2026, that it would not timely file its quarterly report for the period ended September 30 and that prior financial statements must be restated. That is not a garden-variety paperwork hiccup. It reaches back across fiscal 2023, 2024 and...

Continue Reading

Top 5 Most Recently Viewed Articles

Japan's Economic Outlook Dims as Export Weakness Persists

Updated Category News Views 189

Japan's Revised Economic Growth Forecast Recently, Japan's government announced a downward revision of its GDP growth forecast for the current fiscal year. This adjustment is significant as it reflects the ongoing struggles within the economy, particularly in light of weaker export performance that is hindering a fragile recovery. Details on the Growth Projection The...

Continue Reading
The Importance of Employee Recognition in the Workplace

Updated Category News Views 254

The Importance of Employee Recognition in the Workplace Gratitude is a key theme during Thanksgiving, but in the workplace, recognition for employee contributions plays an equally significant role throughout the year. As companies strive to enhance their workplace culture, the value of recognizing employees cannot be overstated. Understanding Employer Perspectives A...

Continue Reading
Class Action Alert for Shareholders of Orthofix Medical

Updated Category News Views 196

Class Action Lawsuit Overview In the current landscape of securities litigation, investors in Orthofix Medical, Inc. have a critical opportunity to engage with a class action lawsuit that addresses significant issues of corporate governance and transparency. This legal action has arisen following severe corporate management changes that have caused share price...

Continue Reading
Understanding Recent Trends in Lowe's Short Interest

Updated Category News Views 107

Understanding Lowe's Companies' Short Interest Lowe's Companies (NYSE: LOW) has seen its short percent of float decrease by 12.78% since the last report. Currently, there are approximately 6.55 million shares sold short, which constitutes 1.16% of all shares available for trading. Given the current trading volume, it would take traders about 2.91 days to cover their short...

Continue Reading
YD Bio Limited and EG Biomed Enhance Clinical Testing with CAP Accreditation

Updated Category News Views 151

Transformative Advancements in Clinical Testing by YD Bio Limited YD Bio Limited, a pioneering biotechnology company known for its advancements in DNA methylation-based cancer detection, recently celebrated a significant milestone through its collaboration with EG Biomed US Inc. This partnership has propelled forward the capabilities of clinical testing, particularly in...

Continue Reading